Abelard Lindsay (@ciltep) profile picture

I am the creator of the CILTEP stack. Software engineering. Medical research. Transhumanism. Making people smarter by designing better nootropics.

Joined March 2013
Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)Photo by Abelard Lindsay (@ciltep)
Abelard Lindsay retweeted
Urolithin A: Potential to enhance autophagic clearance and mitigate neuroinflammation in Alzheimer’s disease sciencedirect.com/science/ar…
1
1
204
Abelard Lindsay retweeted
Spouses of Alzheimer's patients are 6 times more likely to develop Alzheimer's themselves. They share daily saliva exchange for decades. Their oral bacteria converges to the same strains. In 2019 Cortexyme published a paper in Science Advances showing Porphyromonas gingivalis, the bacterium behind gum disease, was present in over 90% of postmortem Alzheimer's brains. They also found its DNA in the cerebrospinal fluid of living Alzheimer's patients. P. gingivalis is the keystone pathogen of periodontitis. The CDC says 47% of American adults over 30 have periodontitis right now. The mechanism is specific. P. gingivalis produces enzymes called gingipains. Two types: one cuts proteins at lysine residues, the other at arginine. Tau, the protein that holds your neuronal scaffolding together, is loaded with both amino acids. In cell culture, gingipains shred soluble tau within one hour of infection. The fragments seed the paired helical filaments that become tangles. Tangles are Alzheimer's. Mice fed P. gingivalis through the mouth grew amyloid plaques in their brains. Hippocampal neurons died. The bacteria crossed the blood-brain barrier and started chewing through the same proteins that fail in human Alzheimer's patients. Cortexyme built a drug called atuzaginstat to block gingipains. Phase 1 was clean. They ran a 643-patient Phase 2/3 trial called GAIN. The FDA hit it with a partial clinical hold for liver toxicity. The drug missed both primary endpoints. In August 2022 Cortexyme shut the program down, renamed itself Quince, and pivoted to bone disease. The subgroup with the highest baseline P. gingivalis loads still showed cognitive improvement on secondary endpoints. The bacteria itself kept showing up in postmortem brains across independent studies after the trial closed. Periodontal disease shows up 10 to 20 years before cognitive symptoms in people who later develop Alzheimer's. By the time someone forgets a name, the bacteria has been working for two decades. The intervention point is upstream of your skull.
68
441
66
1,897
835,998
IMHO, The four pathways are probably keap1/nrf2, htrt, ampk/mtor, alk5/oxytocin. Probably inhibiting fibrotic growth is important like IL inhibitors too.
David Sinclair's lab may have just found the $100 pill that reverses aging. Over the holidays, his team ran what he calls a "hail mary experiment." They gave old mice a "longevity" cocktail three times a week for 4 weeks. He didn't reveal what's in it - only that it contained molecules that work on the four longevity pathways that control the epigenome. They weren't expecting any significant results. Yet every treated mice came back physiologically younger while the controls didn't. Biological age clocks confirmed the reversal. This changes the trajectory for longevity medicine. The gene therapy his company is taking into human trials costs over $10 million to manufacture per batch. It requires a direct injection into the target organ. These oral molecules cost roughly $100 for a month's course. If they're able to put these molecules into a pill that patients can take instead of them using a multi-million dollar gene therapy, they'd save a ton of money. "Imagine in 10 years you just take a pill for 4 weeks and you get younger. That's what we're headed towards. I can see how this is going to happen." The proof of concept exists in animals. Now it's a race to get it into humans. — David Sinclair (@davidasinclair) on Peter Diamandis' (@PeterDiamandis) Moonshots podcast PS. David Sinclair is speaking at SynBioBeta on May 6th this year, discussing the science of slowing and reversing aging. If longevity is the world you're in, the investors, partners, and scientists shaping this space will be in the room. You won't want to miss it: syntheticbiologysummit.com/t…
100
Abelard Lindsay retweeted
He was diagnosed with rare bone cancer. He exhausted the standard of care: surgery, radiation, chemotherapy. There were no viable trials for his case. No approved treatments. No doctor willing to promise any potential for hope. That’s where most journeys end. Not his.
3
16
6
46
13,510
Abelard Lindsay retweeted
Known as cyclin D-binding myb-like transcription factor 1 or DMTF1, the scientists found that this protein's levels are repressed in the “aged” neural stem cells and that restoring it is sufficient to restore the regeneration capabilities of such neural stem cells. healthandme.com/health-welln…
2
18
1,177
Abelard Lindsay retweeted
The 70% Life Extension Nobody Is Talking About Two cheap drugs. One university lab. A 73% increase in remaining lifespan for elderly mice. The longevity breakthrough that should be front-page news and why decentralized science may be the only force that can bring it to your medicine cabinet. Oxytocin and Inhibitor Extend Mouse Lifespan
 Combining oxytocin and Alk5 inhibitor extended elderly mouse lifespan by 73%. Inexpensive drugs, no gene therapy. Major longevity paper. 
Why Important: Demonstrates affordable pharmacological approaches to longevity, bridging natural hormones with targeted inhibition for human applications. doi.org/10.18632/aging.20630…
65
201
16
1,245
78,905
Abelard Lindsay retweeted
The math on this project should mass-humble every AI lab on the planet. 1 cubic millimeter. One-millionth of a human brain. Harvard and Google spent 10 years mapping it. The imaging alone took 326 days. They sliced the tissue into 5,000 wafers each 30 nanometers thick, ran them through a $6 million electron microscope, then needed Google’s ML models to stitch the 3D reconstruction because no human team could process the output. The result: 57,000 cells, 150 million synapses, 230 millimeters of blood vessels, compressed into 1.4 petabytes of raw data. For context, 1.4 petabytes is roughly 1.4 million gigabytes. From a speck smaller than a grain of rice. Now scale that. The full human brain is one million times larger. Mapping the whole thing at this resolution would produce approximately 1.4 zettabytes of data. That’s roughly equal to all the data generated on Earth in a single year. The storage alone would cost an estimated $50 billion and require a 140-acre data center, which would make it the largest on the planet. And they found things textbooks don’t contain. One neuron had over 5,000 connection points. Some axons had coiled themselves into tight whorls for completely unknown reasons. Pairs of cell clusters grew in mirror images of each other. Jeff Lichtman, the Harvard lead, said there’s “a chasm between what we already know and what we need to know.” This is why the next step isn’t a human brain. It’s a mouse hippocampus, 10 cubic millimeters, over the next five years. Because even a mouse brain is 1,000x larger than what they just mapped, and the full mouse connectome is the proof of concept before anyone attempts the human one. We’re building AI systems that loosely mimic neural networks while still unable to fully read the wiring diagram of a single cubic millimeter of the thing we’re trying to imitate. The original is 1.4 petabytes per millionth of its volume. Every AI model on Earth fits in a fraction of that. The brain runs on 20 watts and fits in your skull. The data center required to merely describe one-millionth of it would span 140 acres.
🚨: Scientists mapped 1 mm³ of a human brain ─ less than a grain of rice ─ and a microscopic cosmos appeared.
1,132
11,602
1,384
62,567
4,637,295
Anti-Aging Injection Regrows Knee Cartilage and Prevents Arthritis scitechdaily.com/anti-aging-…
1
1
2
52
I'm beginning to suspect that GPT-5 does very badly on medical queries I've given it because of adaptive safety nerfing. Grok4 is much better for medical stuff now, IMHO.
1
1
92
Aging accelerates at 50. Is this an aging equivalent of puberty? The reason I don't think puberty is part of development and aging isn't is because people with progeria go through puberty at a much younger age and also age much earlier. nature.com/articles/d41586-0…
77
Abelard Lindsay retweeted
Replying to @bayeslord
hitting em with the non fearful rat
8
52
6
1,028
44,336